The structure of an antibody that potently neutralizes a wide range of HIV-1 strains, together with a minimal antigen mimic, is an advance towards the design of vaccines that may elicit protective responses. See Article p.336
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Burton, D. R. et al. Proc. Natl Acad. Sci. USA 108, 11181–11186 (2011).
Wei, X. et al. Nature 422, 307–312 (2003).
McLellan, J. S. et al. Nature 480, 336–343 (2011).
Walker, L. M. et al. Science 326, 285–289 (2009).
Pejchal, R. et al. Proc. Natl Acad. Sci. USA 107, 11483–11488 (2010).
Pancera, M. et al. J. Virol. 84, 8098–8110 (2010).
Zhou, T. et al. Nature 445, 732–737 (2007).
Wu, X. et al. Science 329, 856–861 (2010).
Azoitei, M. L. et al. Science 334, 373–376 (2011).
Chen, L. et al. Science 326, 1123–1127 (2009).
Pejchal, R. et al. Science 334, 1097–1103 (2011).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sattentau, Q. A sweet cleft in HIV's armour. Nature 480, 324–325 (2011). https://doi.org/10.1038/480324a
Published:
Issue Date:
DOI: https://doi.org/10.1038/480324a